Keith L. Davis - Health Economics – United States, RTI Health Solutions

基本信息

浏览量：29

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 232 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Real-World Treatment Patterns and Clinical Outcomes among Patients with Advanced Renal Cell Carcinoma

Elizabeth Esterberg,Shrividya Iyer,Saurabh P. Nagar,Keith L. Davis,Nizar M. Tannir

CLINICAL GENITOURINARY CANCERno. 2 (2024)

引用0浏览0WOS引用

Real-world Treatment Patterns and Clinical Outcomes in Patients Treated with Eribulin after Prior Phosphoinositide 3-Kinase Inhibitor Treatment for Metastatic Breast Cancer

Ravi K. Goyal,Jingchuan Zhang,Keith L. Davis,Martina Sluga-O’Callaghan,Peter A. Kaufman

BREAST CANCER RESEARCH AND TREATMENTno. 1 (2024): 201-210

引用0浏览0WOS引用

Effectiveness of Standard Treatments in Non-Small-cell Lung Cancer with METexon14 Skipping Mutation: a Real-World Study

Muhammad Furqan,Siddharth Karanth,Ravi K. Goyal,Beilei Cai,Julien Rombi,Keith L. Davis,Nydia Caro,Teddy Saliba

FUTURE ONCOLOGY (2024)

引用0浏览0WOS引用

Exploring the Association Between Heart Rate Control and Rehospitalization: A Real-World Analysis of Patients Hospitalized with Heart Failure with Reduced Ejection Fraction

Freny Vaghaiwalla Mody,Ravi K. Goyal,Mayank Ajmera,Keith L. Davis,Alpesh N. Amin

Drugs - Real World Outcomespp.1-11, (2024)

引用0浏览0WOS引用

Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin after Prior Immuno-Oncology or Antibody-Drug Conjugate Therapy

Ravi K. Goyal,Jingchuan Zhang,Keith L. Davis,Martina Sluga-O'Callaghan,Peter A. Kaufman

Breast Cancer Targets and Therapy (2023): 855-865

引用0浏览0WOS引用

Real-world Outcomes in Non-Small-cell Lung Cancer Patients with MET Exon 14 Skipping Mutation and Brain Metastases Treated with Capmatinib

Paul K. Paik,Ravi K. Goyal,Beilei Cai,Mark A. Price,Keith L. Davis,Valerie Derrien Ansquer,Nydia Caro,Teddy R. Saliba

Future oncologyno. 3 (2023): 217-228

引用5浏览0WOS引用

Real-World Assessment of Clinical Outcomes Associated with Immunotherapy (IO) and chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients with Brain Metastases and METexon14 Skipping Mutations Treated in US Community Centers

B. Cai,S. A. Arnold Egloff,R. K. Goyal,B. Cai,N. Caro,M. Frost,S. Mahmud,V. D. Ansquer,K. L. Davis,L. Brisbin,M. Lisi,A. J. McKenzie,S. Paulson

JOURNAL OF THORACIC ONCOLOGYno. 3 (2023): E37-E37

引用0浏览0引用

Abstract P1-03-03: Real-World Treatment Patterns and Clinical Outcomes in Patients Treated with Eribulin after Prior PI3K Inhibitor Therapy for Metastatic Breast Cancer

Ravi K. Goyal,Jingchuan Zhang,Keith L. Davis,Peter A. Kaufman

Cancer research（2023）

引用0浏览0引用

Improved Survival Outcomes in Patients with MET-Dysregulated Advanced NSCLC Treated with MET Inhibitors: Results of a Multinational Retrospective Chart Review

Jürgen Wolf,Pierre-Jean Souquet,Koichi Goto,Alexis Cortot, Christina Baik,Rebecca Heist,Tae Min Kim,Ji-Youn Han,Joel W. Neal,Aaron S. Mansfield,Isabelle Gilloteau,Ngozi Nwana,Maeve Waldron-Lynch,Keith L. Davis,Monica Giovannini,Mark M. Awad

Clinical lung cancerno. 7 (2023): 641-650.e2

引用1浏览0WOS引用

Patient Characteristics and Treatment Patterns in Resectable Early-Stage NSCLC: UK Subgroup Analysis of a Global Real-World Study

Carles Escriu,Sridhar Rathinam,Doreen Kahangire,Saurabh Nagar,Keith Davis,Maria Jimenez,Martin Sandelin, Jason Chow

Lung cancer (2023): S17-S17

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn